ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Removing Translation Bottlenecks With AI

  See how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.

• The Transformative Impact Of EDC Systems In 2025

  The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.

• Crowdsource UAT: An Opportunity For Future Validation

  IQVIA, a leading health information technology and clinical research company, has introduced a new validation model for eTMF patterned after approaches used within the larger tech space.

• How DCTs Became The New Standard

  See how the core features of DCTs have become the new default clinical trial practices for a variety of therapeutic areas, almost four years after the 2020 pandemic brought about their rise.

• Solving Key eCOA Challenges Through Digital Trials—Proof Points!

  Medable has reached some important milestones and shares them in its end-of-year report. Check it out to see what game-changing results they've brought to their customers.

• Connecting The Right Patients To The Right Trial

  Direct outreach to potential participants and communication with their healthcare providers is key to boosting trial awareness and participation, thereby achieving recruitment targets.

• How Do Site Payments Impact Clinical Trial Sustainability?

  Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,

• The Next Competitive Advantage In Clinical Trials Is Execution Intelligence

  AI fails in clinical trials when decision-making is messy. To win, sponsors must fix their "execution blind spot" by structuring how work happens, letting AI turn hidden patterns into strategy.

• Paving The Way For Virtual Trials In Neurology: A Fully Remote ALS Study

  The COVID-19 pandemic has completely changed the way we think about clinical research and care. Clinical trials, a vital component of the drug development process, were heavily disrupted because patients, often with weakened immune systems, could not visit hospitals and research sites.

• Building Patient-Focused eCOA Strategies: Insights And Best Practices

  Discover why the use of electronic clinical outcome assessments (eCOA) in clinical research is becoming an increasingly important part of study design in this article.